It has also been shown that there is a statistically significant difference between IBD patients and controls in thrombocyte volume, protein C, protein S, APC resistance, F1+F2 fragments, and tPA, which are associated with hypercoagulability [54]. The gene discussed is PROS1; the disease is inflammatory bowel disease.